These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 23539377)

  • 1. Problem based review: The patient taking methadone.
    Arora A; Williams K
    Acute Med; 2013; 12(1):51-4. PubMed ID: 23539377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of maintenance treatment in opioid dependence.
    Ward J; Hall W; Mattick RP
    Lancet; 1999 Jan; 353(9148):221-6. PubMed ID: 9923893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid overdose prevention with intranasal naloxone among people who take methadone.
    Walley AY; Doe-Simkins M; Quinn E; Pierce C; Xuan Z; Ozonoff A
    J Subst Abuse Treat; 2013 Feb; 44(2):241-7. PubMed ID: 22980450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning.
    Trujols J; Garijo I; Siñol N; del Pozo J; Portella MJ; Pérez de los Cobos J
    Drug Alcohol Depend; 2012 Jun; 123(1-3):41-7. PubMed ID: 22071121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
    White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
    J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cedar Project: methadone maintenance treatment among young Aboriginal people who use opioids in two Canadian cities.
    Yang J; Oviedo-Joekes E; Christian KW; Li K; Louie M; Schechter M; Spittal P
    Drug Alcohol Rev; 2011 Nov; 30(6):645-51. PubMed ID: 21355933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of methadone maintenance treatment for HIV-positive drug users in Vietnam.
    Tran BX; Ohinmaa A; Duong AT; Do NT; Nguyen LT; Mills S; Houston S; Jacobs P
    AIDS Care; 2012; 24(3):283-90. PubMed ID: 21936718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retention in methadone maintenance treatment in mainland China, 2004-2012: a literature review.
    Zhou K; Zhuang G
    Addict Behav; 2014 Jan; 39(1):22-9. PubMed ID: 24090627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methadone as social control: institutionalized stigma and the prospect of recovery.
    Harris J; McElrath K
    Qual Health Res; 2012 Jun; 22(6):810-24. PubMed ID: 22232295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of methadone maintenance treatment on women offenders' post-release recidivism.
    Farrell-MacDonald S; MacSwain MA; Cheverie M; Tiesmaki M; Fischer B
    Eur Addict Res; 2014; 20(4):192-9. PubMed ID: 24513717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty years of the methadone treatment protocol in Ireland: reflections on the role of general practice.
    Delargy I; Crowley D; Van Hout MC
    Harm Reduct J; 2019 Jan; 16(1):5. PubMed ID: 30654803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misconceptions predict dropout and poor adherence prospectively among newly admitted first-time methadone maintenance treatment clients in Guangzhou, China.
    Gu J; Xu H; Lau JT; Hao Y; Zhong Y; Fan L; Zhao Y; Hao C; Ling W
    Addiction; 2012 Sep; 107(9):1641-9. PubMed ID: 22360534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of long QTc interval in methadone maintenance patients.
    Fonseca F; Marti-Almor J; Pastor A; Cladellas M; Farré M; de la Torre R; Torrens M
    Drug Alcohol Depend; 2009 Jan; 99(1-3):327-32. PubMed ID: 18774239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality and causes of death among users of methadone maintenance treatment in Israel, 1999-2008.
    Rosca P; Haklai Z; Goldberger N; Zohar P; Margolis A; Ponizovsky AM
    Drug Alcohol Depend; 2012 Sep; 125(1-2):160-3. PubMed ID: 22483811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel.
    Peles E; Schreiber S; Adelson M
    Drug Alcohol Depend; 2010 Mar; 107(2-3):141-8. PubMed ID: 19914783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical treatment of opioid dependence within the South African context.
    Weich L
    SADJ; 2010 May; 65(4):168-71. PubMed ID: 20632700
    [No Abstract]   [Full Text] [Related]  

  • 17. The acceptability of combined methadone-naloxone treatment: Consumer and provider views on the potential utility of methadone-naloxone.
    Shearer J; Mammen K; Bell J
    Drug Alcohol Rev; 2010 Mar; 29(2):138-43. PubMed ID: 20447220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low risk for hepatitis C seroconversion in methadone maintenance treatment.
    Peles E; Schreiber S; Rados V; Adelson M
    J Addict Med; 2011 Sep; 5(3):214-20. PubMed ID: 21844836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multilevel analysis of regional and individual effects on methadone maintenance treatment in Taiwan.
    Chen CY; Ting SY; Tan HK; Yang MC
    Value Health; 2012; 15(1 Suppl):S60-4. PubMed ID: 22265069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to first treatment interruption in the Chinese methadone maintenance treatment programme.
    Sullivan SG; Wu Z; Detels R;
    Drug Alcohol Depend; 2013 Dec; 133(2):427-32. PubMed ID: 23896308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.